Andy Ray

Board Member at Veana Therapeutics

Andrew Ray, Ph.D., is the co-founder of KromaTID, Inc., a privately-held company that developed Directional Genomic Hybridization (dGH™) platform technology capable of detecting DNA sequence, location, and orientation in a single test. He has co-authored over 40 publications and holds 7 US and European patents for his work.

Timeline

  • Board Member

    Current role